Ethnic differences in socioeconomic status, diagnosis, treatment, and survival among older women with epithelial ovarian cancer

International Journal of Gynecological Cancer

Volumn 18, Issue 4, 2008, Pages 660-669

  Du, X L ^a   Sun, C C ^b   Milam, M R ^b   Bodurka, D C ^b   Fang, S ^a  

^a UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Ethnicity; Mortality; Ovarian cancer; Racial disparity; Socioeconomic status; Survival

Indexed keywords

ANTINEOPLASTIC AGENT; CYCLOPHOSPHAMIDE; PLATINUM; TAXANE DERIVATIVE;

AFRICAN AMERICAN; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER MORTALITY; CANCER PATIENT; CANCER SURVIVAL; CAUCASIAN; COHORT ANALYSIS; COMORBIDITY; DRUG EFFICACY; ETHNIC DIFFERENCE; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; OVARY CANCER; PRIORITY JOURNAL; SOCIOECONOMICS;

AFRICAN AMERICANS; AGE FACTORS; AGED; AGED, 80 AND OVER; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; NEOPLASMS, GLANDULAR AND EPITHELIAL; OVARIAN NEOPLASMS; SOCIAL CLASS; SURVIVAL ANALYSIS; UNITED STATES;

EID: 47649089743     PISSN: 1048891X     EISSN: 15251438     Source Type: Journal    
DOI: 10.1111/j.1525-1438.2007.01081.x     Document Type: Article

References (71)

1. Ries LAG, Melbert D, Krapcho M et al. SEER cancer statistics review, 1975-2004. Bethesda, MD : National Cancer Institute. Available at : http://seer.cancer.gov/csr/1975_2004/. Accessed April 17, 2007.
2. American Cancer Society. Cancer facts & figures 2006. Available at : http://www.cancer.org/downloads/STT/CAFF2006PWSecured.pdf. Accessed December 5, 2006.
3. Gertig D, Hunter D. Ovarian cancer. In : Adami HO, Hunter D, Trichopoulos D, eds. Textbook of cancer epidemiology. New York, NY : Oxford University Press, 2002 : 378 99.
4. National Institutes of Health. National Institutes of Health consensus development conference statement: ovarian cancer - screening, treatment and follow-up. Gynecol Oncol 1994 55 (Suppl S4 14.
5. Cannistra SA. Cancer of the ovary. N Engl J Med 2004 351 : 2519 29.
6. Cannistra SA, Bast RC Jr., Berek JS et al. Progress in the management of gynecologic cancer: consensus summary statement. J Clin Oncol 2003 21 (Suppl 129 32.
7. Hugosson J, Aus G, Lilja H, Lodding P, Pihl CG. Results of a randomized, population-based study of biennial screening using serum prostate-specific antigen measurement to detect prostate carcinoma. Cancer 2004 100 : 1397 405.
8. Harries M, Kaye SB. Recent advances in the treatment of epithelial ovarian cancer. Expert Opin Investig Drugs 2001 10 : 1715 24.
9. Harries M, Gore M. Part I: chemotherapy for epithelial ovarian cancer-treatment at first diagnosis. Lancet Oncol 2002 3 : 529 36.
10. Berkenblit A, Cannistra SA. Advances in the management of epithelial ovarian cancer. J Reprod Med 2005 50 : 426 38.
11. Kyrgiou M, Salanti G, Pavlidis N, Paraskevaidis E, Ioannidis JP. Survival benefits with diverse chemotherapy regimens for ovarian cancer: meta-analysis of multiple treatments. J Natl Cancer Inst 2006 98 : 1655 63.
12. Averette HE, Janicek MF, Menck HR. The National Cancer Data Base report on ovarian cancer. American College of Surgeons Commission on Cancer and the American Cancer Society. Cancer 1995 76 : 1096 103.
13. Partridge EE, Phillips JL, Menck HR. National Cancer Data Base report on ovarian cancer treatment in United States hospitals. Cancer 1996 78 : 2236 46.
14. Munoz KA, Harlan LC, Trimble EL. Patterns of care for women with ovarian cancer in the United States. J Clin Oncol 1997 15 : 3408 15.
15. Parham G, Phillips JL, Hicks ML et al. The National Cancer Data Base report on malignant epithelial ovarian carcinoma in African-American women. Cancer 1997 80 : 816 26.
16. Shavers VL, Brown ML. Racial and ethnic disparities in the receipt of cancer treatment. J Natl Cancer Inst 2002 94 : 334 57.
17. Sundararajan V, Hershman D, Grann VR, Jacobson JS, Neugut AI. Variations in the use of chemotherapy for elderly patients with advanced ovarian cancer: a population-based study. J Clin Oncol 2002 20 : 173 8.
18. Cress RD, O'Malley CD, Leiserowitz GS, Campleman SL. Patterns of chemotherapy use for women with ovarian cancer: a population-based study. J Clin Oncol 2003 21 : 1530 5.
19. Harlan LC, Clegg LX, Trimble EL. Trends in surgery and chemotherapy for women diagnosed with ovarian cancer in the United States. J Clin Oncol 2003 21 : 3488 94.
20. Goodman MT, Howe HL. Descriptive epidemiology of ovarian cancer in the United States, 1992-1997. Cancer 2003 97 (Suppl 2615 30.
21. Kosary C, Trimble EL. Treatment and survival for women with fallopian tube carcinoma: a population-based study. Gynecol Oncol 2002 86 : 190 1.
22. Hershman D, Fleischauer AT, Jacobson JS, Grann VR, Sundararajan V, Neugut AI. Patterns and outcomes of chemotherapy for elderly patients with stage II ovarian cancer: a population-based study. Gynecol Oncol 2004 92 : 293 9.
23. Hershman D, Jacobson JS, McBride R et al. Effectiveness of platinum-based chemotherapy among elderly patients with advanced ovarian cancer. Gynecol Oncol 2004 94 : 540 9.
24. Elit L, Chartier C, Oza A et al. Outcomes for systemic therapy in women with ovarian cancer. Gynecol Oncol 2006 103 : 554 8.
25. Polsky D, Armstrong KA, Randall TC et al. Variation in chemotherapy utilization in ovarian cancer: the relative contribution of geography. Health Serv Res 2006 41 : 2201 18.
26. Goff BA, Matthews BJ, Wynn M et al. Ovarian cancer: patterns of surgical care across the United States. Gynecol Oncol 2006 103 : 383 90.
27. Goff BA, Matthews BJ, Larson EH et al. Predictors of comprehensive surgical treatment in patients with ovarian cancer. Cancer 2007 109 : 2031 42.
28. Howard G, Anderson RT, Russell G et al. Race, socioeconomic status, and cause-specific mortality. Ann Epidemiol 2000 10 : 214 23.
29. Piffath TA, Whiteman MK, Flaws JA, Fix AD, Busht TL. Ethnic differences in cancer mortality trends in the US, 1950-1992. Ethn Health 2001 6 : 105 19.
30. Barnholtz-Sloan JS, Tainsky MA, Abrams J et al. Ethnic differences in survival among women with ovarian carcinoma. Cancer 2002 94 : 1886 93.
31. McGuire V, Herrinton L, Whittemore AS. Race, epithelial ovarian cancer survival, and membership in a large health maintenance organization. Epidemiology 2002 13 : 231 4.
32. McGuire V, Jesser CA, Whittemore AS. Survival among U.S. women with invasive epithelial ovarian cancer. Gynecol Oncol 2002 84 : 399 403.
33. Howe HL, Tung KH, Coughlin S. Race/ethnic variations in ovarian cancer mortality in the United States, 1992-1997. Cancer 2003 97 (Suppl 2686 93.
34. O'Malley CD, Cress RD, Campleman SL, Leiserowitz GS. Survival of Californian women with epithelial ovarian cancer, 1994-1996: a population-based study. Gynecol Oncol 2003 91 : 608 15.
35. Chan JK, Cheung MK, Husain A et al. Patterns and progress in ovarian cancer over 14 years. Obstet Gynecol 2006 108 : 521 8.
36. Chan JK, Urban R, Cheung MK et al. Ovarian cancer in younger vs older women: a population-based analysis. Br J Cancer 2006 95 : 1314 20.
37. Smith HO, Berwick M, Verschraegen CF et al. Incidence and survival rates for female malignant germ cell tumors. Obstet Gynecol 2006 107 : 1075 85.
38. Tammemagi CM. Racial/ethnic disparities in breast and gynecologic cancer treatment and outcomes. Curr Opin Obstet Gynecol 2007 19 : 31 6.
39. Potosky AL, Riley GF, Lubitz JD et al. Potential for cancer related health services research using a linked Medicare-tumor registry database. Med Care 1993 31 : 732 48.
40. Warren JL, Klabunde CN, Schrag D et al. Overview of the SEER-Medicare data: content, research applications, and generalizability to the United States elderly population. Med Care 2002 40 (Suppl IV3 18.
41. Du XL, Key CR, Dickie L et al. External validation of Medicare claims for breast cancer chemotherapy compared with medical chart reviews. Med Care 2006 44 : 124 31.
42. National Cancer Institute. SEER-Medicare: identification of diagnosis & procedure codes. Available at : http://healthservices.cancer.gov/ seermedicare/considerations/identification.html. Accessed December 5, 2006.
43. National Cancer Institute. ICD-O-2 to ICD-9-(CM) (NIH Publication No. 93-2007 US Department of Health and Human Services, Public Health Service, National Institutes of Health, 1992.
44. Quirk JT, Natarajan N. Ovarian cancer incidence in the United States, 1992-1999. Gynecol Oncol 2005 97 : 519 23.
45. National Cancer Institute. The SEER program code manual. Revised edition (NIH Publication No. 94-1999). Bethesda, MD : National Cancer Institute, 1994.
46. US Public Health Services. International classification of diseases, 9th revision, clinical modification, 5th edn. Los Angeles, CA : Practice Management Information Corporation, 1996.
47. American Medical Association. Physicians' current procedural terminology - CPT 2000. Chicago, IL : American Medical Association, 2000.
48. Health Care Financing Administration. HCFA Common Procedure Coding System (HCPCS): National Level II Medicare Codes. Los Angeles, CA : Practice Management Information Corporation, 2000.
49. Earle CC, Schrag D, Neville BA et al. Effect of surgeon specialty on processes of care and outcomes for ovarian cancer patients. J Natl Cancer Inst 2006 98 : 172 80.
50. Du XL, Goodwin JS. Patterns of use of chemotherapy for breast cancer in older women: findings from Medicare claims data. J Clin Oncol 2001 19 : 1455 61.
51. Percy C, Stanek E III., Gloeckler L. Accuracy of cancer death certificates and its effect on cancer mortality statistics. Am J Public Health 1981 71 : 242 50.
52. Smith Sehdev AE, Hutchins GM. Problems with proper completion and accuracy of the cause-of-death statement. Arch Intern Med 2001 161 : 277 84.
53. Du XL, Fang S, Coker AL et al. Racial disparity and socioeconomic status in association with survival in older men with local/regional stage prostate carcinoma: findings from a large community-based cohort. Cancer 2006 106 : 1276 85.
54. Du XL, Chan W, Giordano S et al. Variation in modes of chemotherapy administration for breast carcinoma and association with hospitalization for chemotherapy-related toxicity. Cancer 2005 104 : 913 24.
55. Bach PB, Guadagnoli E, Schrag D et al. Patient demographic and socioeconomic characteristics in the SEER-Medicare database applications and limitations. Med Care 2002 40 (Suppl IV19 25.
56. Allison PD. Survival analysis using the SAS system: a practical guide. Cary, NC : SAS Institute Inc., 1995.
57. McCarthy EP, Burns RB, Coughlin SS et al. Mammography use helps to explain differences in breast cancer stage at diagnosis between older black and white women. Ann Intern Med 1998 128 : 729 36.
58. Smith-Bindman R, Miglioretti DL, Lurie N et al. Does utilization of screening mammography explain racial and ethnic differences in breast cancer? Ann Intern Med 2006 144 : 541 53.
59. Eheman CR, Benard VB, Blackman D et al. Breast cancer screening among low-income or uninsured women: results from the National Breast and Cervical Cancer Early Detection Program, July 1995 to March 2002 (United States). Cancer Causes Control 2006 17 : 29 38.
60. Sirovich BE, Schwartz LM, Woloshin S. Screening men for prostate and colorectal cancer in the United States: does practice reflect the evidence? JAMA 2003 289 : 1414 20.
61. Roy HK, Backman V, Goldberg MJ. Colon cancer screening: the good, the bad, and the ugly. Arch Intern Med 2006 166 : 2177 9.
62. National Institutes of Health. Consensus development conference statement: cervical cancer. 1996 43 : 1 38. Available at : http://consensus.nih. gov/1996/1996CervicalCancer102html.htm. Accessed March 7, 2007.
63. Hodgson DC, Fuchs CS, Ayanian JZ. Impact of patient and provider characteristics on the treatment and outcomes of colorectal cancer. J Natl Cancer Inst 2001 93 : 501 15.
64. Bach PB, Schrag D, Brawley OW, Galaznik A, Yakren S, Begg CB. Survival of African Americans and Caucasians after a cancer diagnosis. JAMA 2002 287 : 2106 13.
65. Schrag D, Earle C, Xu F et al. Associations between hospital and surgeon procedure volumes and patient outcomes after ovarian cancer resection. J Natl Cancer Inst 2006 98 : 163 71.
66. Silber JH, Rosenbaum PR, Polsky D et al. Does ovarian cancer treatment and survival differ by the specialty providing chemotherapy? J Clin Oncol 2007 25 : 1169 75.
67. Cannistra SA. Gynecologic oncology or medical oncology: what's in a name? J Clin Oncol 2007 25 : 1157 9.
68. Faggiano F, Partanen T, Kogevinas M, Boffetta P. Socioeconomic differences in cancer incidence and mortality. IARC Sci Publ 1997 138 : 65 176.
69. Ward E, Jemal A, Cokkinides V et al. Cancer disparities by race/ethnicity and socioeconomic status. CA Cancer J Clin 2004 54 : 78 93.
70. Newman LA, Griffith KA, Jatoi I et al. Meta-analysis of survival in African American and white American patients with breast cancer: ethnicity compared with socioeconomic status. J Clin Oncol 2006 24 : 1342 9.
71. Du XL, Fang S, Vernon SW et al. Racial disparities and socioeconomic status in association with survival in a large population-based cohort of elderly patients with colon cancer. Cancer 2007 110 : 660 9.